Microbial cell components induced tolerance to flagellin-stimulated inflammation through Toll-like receptor pathways in intestinal epithelial cells

Cytokine

Volumn 60, Issue 3, 2012, Pages 806-811

  Li, Nan ^a   Quidgley, Maria C ^a   Kobeissy, Firas H ^a   Joseph, Jessica ^a   Neu, Josef ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Flagellin; Intestinal epithelial cells; Systems biology; Tolerance; Toll like receptors

Indexed keywords

CYTOKINE RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLAGELLIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NUCLEAR FACTOR KAPPA B1; PROTEIN FOS; PROTEIN MAP4K4; PROTEIN TNFRSF1A; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL COMPONENT; CELL DEATH; CELL STIMULATION; CELL STRAIN CACO 2; COMPUTER PROGRAM; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; IMMUNOLOGICAL TOLERANCE; INCUBATION TIME; INFECTION; INFLAMMATION; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; UPREGULATION;

APOPTOSIS; CACO-2 CELLS; CHEMOKINE CXCL10; DOWN-REGULATION; EPITHELIAL CELLS; ESCHERICHIA COLI; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FLAGELLIN; GENE EXPRESSION PROFILING; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-1BETA; INTERLEUKIN-8; INTESTINAL MUCOSA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-FOS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTORS; UP-REGULATION;

BACTERIA (MICROORGANISMS);

EID: 84867984139     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.08.003     Document Type: Article

References (40)

1. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
2. Rhee S.H., Keates A., Moyer M.P., Pothoulakis C. MEK is a key modulator for TLR5-induced interleukin-8 and MIP3 gene expression in non-transformed human colonic epithelial cells. J Biol Chem 2004, 279:25179-25188.
3. Abreu M., Fukata M., Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005, 174:4453-4460.
4. Furrie E., Macfarlane S., Thomson G., Macfarlane G.T. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005, 115:565-574.
5. Sansonetti P.J., Medzhitov R. Learning tolerance while fighting ignorance. Cell 2009, 138:416-420.
6. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80.
7. Akira S. Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B 2009, 85:143-156.
8. Figdor C.G., van Kooyk Y., Adema G.J. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002, 2:77-84.
9. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884.
10. Thompson A.J.V., Locarnini S.A. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol 2007, 85:435-445.
11. Sharma R., Young C., Neu J. Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J Biomed Biotechnol 2010, 2010:305879.
12. Abreu M.T. Toll-like receptor signaling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010, 10:131-141.
13. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003, 15:5-11.
14. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011, 30:16-34.
15. Wells J.M., Loonen L., Karczewski J.M. The role of innate signaling in the homeostasis of tolerance and immunity in the intestine. Zentralbl Bakteriol 2010, 300:41-48.
16. Neish A.S. The gut microflora and intestinal epithelial cells: a continuing dialogue. Microbes Infect 2002, 4:309-317.
17. Claud E.C., Lu L., Anton P.M., Savidge T., Walker W.A., Cherayil B.J. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA 2004, 101:7404-7408.
18. Boyle R.J., Robins-Browne R.M., Tang M.L. Probiotic use in clinical practice. what are the risks?. Am J Clin Nutr 2006, 83:1256-1264.
19. Besselink M.G., van Santvoort H.C., Buskens E., et al. Dutch acute pancreatitis study group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo-controlled trial. Lancet 2008, 371:651-659.
20. Wassenaar T.M., Klein G. Safety aspects and implications of regulation of probiotic bacteria in food and food supplements. J Food Protect 2008, 71:1734-1741.
21. Honeycutt T.C., El Khashab M., Wardrop R.M., et al. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med 2007, 8:452-458.
22. Liong M.T. Safety of probiotics: translocation and infection. Nutr Rev 2008, 66:192-202.
23. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., et al. Probiotics for treating eczema. Cochrane Database Syst Rev 2008, 4:CD006135.
24. Lin H.C., Hsu C.H., Chen H.L., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008, 122:693-700.
25. Neu J. Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr Rev 2007, 65:282-285.
26. Singhi S. Probiotics in the critically ill: handle with care!. Pediatr Crit Care Med 2007, 8:499-501.
27. Taylor A.L., Dunstan J.A., Prescott S.L. Probiotic supplementation for the first 6months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007, 119:184-191.
28. Lopez M., Li N., Kataria J., Russell M., Neu J. Live and ultraviolet-inactivated Lactobacillus rhamnosus gg decrease flagellin-induced interleukin-8 production in caco-2 cells. J Nutr Immunol 2008, 138:2264-2268.
29. Kataria J., Li N., Wynn J.L., Neu J. Probiotic microbes: do they need to be alive to be beneficial?. Nutr Rev 2009, 67:546-550.
30. Mizel S.B., Snipes J.A. Gram-negative flagellin-induced self-tolerance is associated with a block in interleukin-1 receptor associated kinase release from Toll-like receptor 5. J Biol Chem 2002, 277:22414-22420.
31. Sun J., Fegan P.E., Desai A.S., Madara J.L., Hobert M.E. Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007, 292:G767-G778.
32. McCall C.E., Grosso-Wilmoth L.M., LaRue K., Guzman R.N., Cousart S.L. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993, 91:853-861.
33. Medvedev A.E., Kopydlowski K.M., Vogel S.N. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J Immunol 2000, 164:5564-5574.
34. Verma A., Arora S.K., Kuravi S.K., Ramphal R. Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect Immunol 2005, 73:8237-8246.
35. Kajava A.V., Vasselon T. A network of hydrogen bonds on the surface of TLR2 controls ligand positioning and cell signaling. J Biol Chem 2010, 285:6227-6234.
36. Oshima N., Ishihara S., Rumi M.A., Aziz M.M., Mishima Y., Kadota C., et al. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin Exp Immunol 2010, 159:185-198.
37. Mendes M.E., Baggio-Zappia G.L., Coló Brunialti M. Differential expression of Toll-like receptor signaling cascades in LPS-tolerant human peripheral blood mononuclear cells. Immunobiology 2011, 216:285-295.
38. Vartanian K.B., Stevens S.L., Marsh B.J., Williams-Karnesky R., Lessov N.S., Stenzel-Poore M.P. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J Neuroinflammation 2011, 8:140.
39. de Vos A.F., Pater J.M., van den Pangaart P.S., de Kruif M.D., van 't Veer C., van der Poll T. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol 2009, 183:533-542.
40. Jacinto R., Hartung T., McCall C., Li L. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance. distinct alterations in IL-1 receptor-associated kinase. J Immunol 2002, 168:6136-6141.